REATA PHARMACEUTICALS INC Deferred Revenue Recognized
REATA PHARMACEUTICALS INC reported Deferred Revenue Recognized of $1.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2019-02-28
- REATA PHARMACEUTICALS INC contract with customer, liability, revenue recognized for fiscal 2018 was $1.00M, a 100.00% increase from fiscal 2017.
- REATA PHARMACEUTICALS INC contract with customer, liability, revenue recognized for fiscal 2017 was $500.00K.
- REATA PHARMACEUTICALS INC contract with customer, liability, revenue recognized for fiscal 2016 was $0.00.
| Period end | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|
| 2018-12-31 | $1.00M 10-K · filed 2019-02-28 |
| 2017-12-31 | $500.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |